Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Gaza: Red Cross Field Hospital in Rafah undergoes overhaul to continue addressing urgent health care needs
International Committee of the Red Cross
“The entry of medical equipment and supplies for the Red Cross Field Hospital is a positive step towards responding to the medical needs of people in Gaza,” said Julien Lerisson, the ICRC’s head of delegation in Israel and the Occupied...
Two years on: upgrading the Red Cross Field Hospital in Rafah
International Committee of the Red Cross
Over the last two years, the Red Cross Field Hospital has been a constant in Gaza's fractured health landscape.
Thai University Approves Helsinki-Standard Study of Maha Taksa Astrology Tradition
EIN Presswire
Mae Fah Luang University's Human Research Ethics Committee has approved a qualitative study of Maha Taksa, the Thai astrology system, under Helsinki standards.
Ten Leading Elevator Modernization Enterprises in China 2026: Driving Urban Renewal & Smart Vertical Mobility
EIN Presswire
Focusing on intelligent retrofit solutions, energy-saving technologies, and safety upgrades for aging elevator fleets.
Gluten-Free Products Market Gaining Momentum with Health-Driven Consumer Trends
GlobeNewswire, Inc.
Delray Beach, FL, April 30, 2026 (GLOBE NEWSWIRE) -- The global gluten-free products market is experiencing steady expansion as consumers increasingly shift toward healthier and more personalized dietary choices.
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours Orion Corporation...
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received...
Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study
GlobeNewswire, Inc.
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC to support broader adoption PETACH TIKVA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Nanox...
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
GlobeNewswire, Inc.
Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program footprint from 11 countries to more than 30 by 2030, including across five cities in the U.S. Builds...
Deafmetal Opens Seed Round and Launches Audiology Clinic Program to Scale Hearing Aid Jewelry Globally
EIN Presswire
HELSINKI, FINLAND, April 1, 2026 /EINPresswire.com/ -- Deafmetal, the Finnish design-driven hearing health brand transforming hearing devices into objects of identity and style, today announces the launch of the Deafmetal Audiology Clinic...
Printing Paper Market on Course to Reach $457.5 Billion by 2035 as Packaging Replaces Publishing as the Growth Engine
EIN Presswire
The Asia-Pacific region is responsible for 41.2% of 2025 revenue and has the fastest compound annual growth rate (CAGR) of 6.2% through 2035 NJ, UNITED STATES, August 19, 2026 /EINPresswire.com/ -- The global printing paper market is navigating...
Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines
GlobeNewswire, Inc.
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS 1 APRIL 2026 at 16.00 EEST Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines Orion...
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
GlobeNewswire, Inc.
— QSIVA offers clinically meaningful weight loss supported by a well-established safety profile, now available at a reduced price across Nordics and Poland AMSTERDAM, March 25, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a...
Albanian-Finnish Startup Bliss Raises $270K to Build Culturally Intelligent AI for Therapy
GlobeNewswire, Inc.
Helsinki, Finland, March 11, 2026 (GLOBE NEWSWIRE) -- Bliss, a Finland-headquartered mental health startup originally founded in Albania, has raised $270,000 in angel funding led by Keiretsu Forum, Finest Love VC and Plug and Play, to build what...
Finland Weighs Ban on Social Media for Under-15s
MENAFN
(MENAFN) Finland's leader is pushing for a sweeping social media prohibition targeting children younger than 15, warning that excessive digital consumption is fueling a health emergency among the nation's youth.
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
GlobeNewswire, Inc.
Espoo, Finland, March 16, 2026: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri Huttunen, will be...
Global Health Leaders to Convene in London for Inaugural International Case Management Conference
GlobeNewswire, Inc.
London, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- Health system and health plan leaders from around the world will gather in London this September for the Inaugural International Case Management Conference, a first-of-its-kind global...
PsyMetRiC – a new tool to predict physical health risks in young people with psychosis
EIN Presswire
PsyMetRiC is designed to be simple and easy to use in clinical practice, and requires only simple, routinely-recorded information to make predictions.
Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia
GlobeNewswire, Inc.
HELSINKI, March 12, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and anticoagulant effects,...
Herantis Pharma releases 2H and FY 2025 report today
GlobeNewswire, Inc.
Herantis Pharma Plc | Company Release | March 5, 2026 at 08:00:00 EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease,...
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.